平安好醫生(01833.HK)與湯臣倍健簽署戰略合作協議
平安好醫生(01833.HK)與湯臣倍健簽署戰略合作協議,期望通過湯臣倍健的科學產品和平安健康的健康管理服務良好結合,發揮「商品+服務」創新模式優勢,滿足廣大用戶的綜合性健康需求,助力提升全民健康素養水平。
平安健康高級副總裁伍烘亮表示,「商品+服務」融合模式是一次大膽的創新,通過與湯臣倍健在多渠道多領域展開全面合作,能使平安健康的用戶得到更好的商品服務。在健康領域,雙方都是各有所長且高度互補的企業,雙方可以通過「商品+健康管理服務」的高度融合,實現場景、用戶打通,使雙方互利共贏。
湯臣倍健電商事業部總經理譚青表示,希望通過平安健康的醫療、健康服務,結合自身的產品,對其資深用戶進行深度捆綁,帶來更好的健康服務解決方案。依託平安健康在健康管理的優質服務與良好體驗,相信能夠幫助湯臣倍健的忠實用戶得到更好的健康體驗。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.